Evidence map›Paper›PMID 41237236›Full record

ArticleScience advances2025

Mapping neurophysiological and molecular profiles of heterogeneity and homogeneity in schizophrenia-bipolar disorder.

Fali Li, Guangying Wang, Sarah Genon, Simon B Eickhoff, Runyang He, Chanlin Yi, Debo Dong, Dezhong Yao, Lin Jiang, Wei Wu and 1 more

Abstract read
In one paragraph

Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Fali LiThe Clinical Hospital of Chengdu Brain Science Institute, MOE Key Lab for Neuroinformation, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, 611731, China.ORCID 0000-0002-2450-4591
Guangying WangThe Clinical Hospital of Chengdu Brain Science Institute, MOE Key Lab for Neuroinformation, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, 611731, China.ORCID 0000-0002-6622-3157
Sarah GenonInstitute of Neuroscience and Medicine, Brain and Behavior (INM-7), Research Center Jülich, Jülich, Germany.ORCID 0000-0002-7087-7882
Simon B EickhoffInstitute of Neuroscience and Medicine, Brain and Behavior (INM-7), Research Center Jülich, Jülich, Germany.
Runyang HeThe Clinical Hospital of Chengdu Brain Science Institute, MOE Key Lab for Neuroinformation, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, 611731, China.ORCID 0009-0008-0378-8995
Chanlin YiThe Clinical Hospital of Chengdu Brain Science Institute, MOE Key Lab for Neuroinformation, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, 611731, China.ORCID 0000-0001-7989-2440
Debo DongInstitute of Neuroscience and Medicine, Brain and Behavior (INM-7), Research Center Jülich, Jülich, Germany.ORCID 0000-0002-8931-2806
Dezhong YaoThe Clinical Hospital of Chengdu Brain Science Institute, MOE Key Lab for Neuroinformation, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, 611731, China.ORCID 0000-0002-8042-879X
Lin JiangThe Clinical Hospital of Chengdu Brain Science Institute, MOE Key Lab for Neuroinformation, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, 611731, China.ORCID 0000-0002-7892-118X
Wei WuDepartment of Neurology, Songjiang Hospital and Songjiang Research Institute, Shanghai Key Laboratory of Emotions and Affective Disorders, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.ORCID 0000-0003-3938-8359
Peng XuThe Clinical Hospital of Chengdu Brain Science Institute, MOE Key Lab for Neuroinformation, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, 611731, China.ORCID 0009-0004-6198-8195

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The heterogeneity of psychotic disorders leads to instability in subjectively defined diagnoses. This study used a machine learning framework termed common orthogonal basis extraction (COBE) to decompose electroencephalography-based functional connectivity (FC) in patients with psychotic bipolar disorder (PBD), schizophrenia (SCZ), and schizoaffective disorder (SAD) into individualized and shared subspaces. The results demonstrated that individualized FCs captured disease heterogeneity and predicted symptom severity more accurately than raw FCs, while shared FCs revealed diagnosis-specific abnormalities and achieved an accuracy of 79.30% in differentiating PBD, SCZ, and SAD. Furthermore, molecular decoding implicated regionally selective serotonin systems and astrocytes in the neurobiological differences among disorders, suggesting disorder-specific pharmacological targets. Critically, these findings were replicated in an independent cohort, confirming the effectiveness of the COBE framework in mining neurophysiological and molecular profiles of schizophrenia-bipolar disorder. These findings advance mechanistic understanding of psychotic disorders and offer a promising avenue toward objective, clinically relevant tools for psychotic evaluation.

Indexed as

Bipolar DisorderSchizophreniaAdultBrain MappingElectroencephalographyFemaleHumansMachine LearningMaleMiddle AgedPsychotic Disorders

Identifiers

PMID41237236
PMCPMC12617522

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.